- Home
- QNCX vs FLYX Comparison
QNCX vs FLYX Comparison
Compare QNCX & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- FLYX
- Stock Information
- Founded
- QNCX 2012
- FLYX 2015
- Country
- QNCX United States
- FLYX United States
- Employees
- QNCX N/A
- FLYX N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- FLYX Blank Checks
- Sector
- QNCX Health Care
- FLYX Finance
- Exchange
- QNCX Nasdaq
- FLYX Nasdaq
- Market Cap
- QNCX 88.6M
- FLYX 79.8M
- IPO Year
- QNCX 2019
- FLYX N/A
- Fundamental
- Price
- QNCX $1.60
- FLYX $3.62
- Analyst Decision
- QNCX Strong Buy
- FLYX
- Analyst Count
- QNCX 6
- FLYX 0
- Target Price
- QNCX $8.00
- FLYX N/A
- AVG Volume (30 Days)
- QNCX 271.4K
- FLYX 16.1K
- Earning Date
- QNCX 11-12-2025
- FLYX 11-13-2025
- Dividend Yield
- QNCX N/A
- FLYX N/A
- EPS Growth
- QNCX N/A
- FLYX N/A
- EPS
- QNCX N/A
- FLYX N/A
- Revenue
- QNCX N/A
- FLYX $347,746,000.00
- Revenue This Year
- QNCX N/A
- FLYX $28.47
- Revenue Next Year
- QNCX N/A
- FLYX $22.44
- P/E Ratio
- QNCX N/A
- FLYX N/A
- Revenue Growth
- QNCX N/A
- FLYX 17.09
- 52 Week Low
- QNCX $0.72
- FLYX $1.90
- 52 Week High
- QNCX $2.45
- FLYX $6.90
- Technical
- Relative Strength Index (RSI)
- QNCX 37.36
- FLYX 42.30
- Support Level
- QNCX $1.76
- FLYX $3.51
- Resistance Level
- QNCX $1.88
- FLYX $3.97
- Average True Range (ATR)
- QNCX 0.10
- FLYX 0.29
- MACD
- QNCX -0.03
- FLYX -0.01
- Stochastic Oscillator
- QNCX 9.28
- FLYX 14.87
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.